Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter

BACKGROUND: Neoadjuvant chemotherapy (NAC) is used in patients with breast cancer to reduce tumor focus, metastatic risk, and patient mortality. Monitoring NAC effects is necessary to capture resistant patients and stop or change treatment. The existing methods for evaluating NAC results have some l...

Descripción completa

Detalles Bibliográficos
Autores principales: Piotrzkowska-Wróblewska, Hanna, Dobruch-Sobczak, Katarzyna, Klimonda, Ziemowit, Karwat, Piotr, Roszkowska-Purska, Katarzyna, Gumowska, Magdalena, Litniewski, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417657/
https://www.ncbi.nlm.nih.gov/pubmed/30870478
http://dx.doi.org/10.1371/journal.pone.0213749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417657/
https://www.ncbi.nlm.nih.gov/pubmed/30870478
http://dx.doi.org/10.1371/journal.pone.0213749

Ejemplares similares